Purpose: To determine the diagnostic accuracy of standardized first trimester (11 +0 –14 +0 weeks of gestation) fetal echocardiography (FE) for the detection of congenital heart defects (CHDs). Methods: Pregnant women who underwent FE in the first trimester at a tertiary center between November 2021 and December 2022 were included in this retrospective study. In the first trimester, FE; heart position with cardiac axis, heart rhythm, four‐chamber view with two distinct ventricles, left ventricular outflow tract view, and three vessel trachea view were evaluated. CHDs were grouped as mild (do not require treatment or can be easily treated without affecting the child in the long term) and severe (expected to require surgery or cardiac catheterization, may affect the child in the long term) according to their severity. Results: A total of 311 pregnant women were included in the study, and 22 (7.1%) fetuses were diagnosed with CHDs. Of the 22 fetuses, 6 (27.3%) had severe CHDs, and 16 (72.7%) had mild CHDs. All severe CHDs were correctly diagnosed on first trimester FE. The sensitivity of first trimester FE for overall CHDs was 54.5%, and specificity was 100%. The performance of first trimester FE in the diagnosis of severe CHDs was excellent, with 100% sensitivity and 100% specificity. Conclusion: First trimester FE has high detection rates for early diagnosis of severe CHDs. Standardized first trimester FE may allow early diagnosis of fetuses with CHDs and contribute to the appropriate management of these pregnancies.
BackgroundTo implement the newly updated 2025 European Society of Cardiology (ESC) modified World Health Organization (mWHO) 2.0 classification in a cohort of pregnant women with cardiovascular disease, and to evaluate the clinical impact of disease acuity, referral timing, and specialized maternal-fetal medicine (MFM) surveillance intensity on granular obstetric and neonatal outcomes.MethodsThis retrospective, observational cohort study analyzed 82 maternal-fetal dyads managed at a tertiary center. Patients were stratified into a Low-Risk Group (mWHO 2.0 Class I–II; n=40) and a Moderate-to-Extreme High-Risk Group (Classes II–III,III, and IV; n=42). Surveillance intensity was measured by referral timing and total MFM visits. Multivariate logistic and linear regression models were constructed to identify independent predictors of adverse perinatal endpoints.ResultsValvular disease predominated (54.9%). A paradoxical referral pattern emerged, with 71.4% of high-risk versus 50.0% of low-risk patients referred late (≥14 weeks; p=0.047). In multivariate logistic regression, high-risk mWHO 2.0 status was the sole independent predictor for preterm birth (aOR: 4.292, p=0.007) and NICU admission (aOR: 2.662, p=0.045). Multiple linear regression showed neonatal birth weight was uniquely governed by gestational age (p<0.001) and maternal age (p=0.014), rather than mWHO tier (p=0.675). The high-risk group had a 90.2% Cesarean rate (p=0.040).ConclusionThe 2025 mWHO 2.0 tier robustly predicts neonatal morbidity, which is iatrogenically driven by indicated preterm deliveries to prevent maternal failure. Systemic adjustments are required to improve late referral patterns and optimize early multidisciplinary care.
10 October 2026 in Irish Journal of Medical Science (1971 -)